Oxford BioDynamics (STU:LMQ) Ending Cash Position : €2.18 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Oxford BioDynamics Ending Cash Position?

Oxford BioDynamics's Ending Cash Position for the quarter that ended in Sep. 2024 was €2.18 Mil.

Oxford BioDynamics's quarterly Ending Cash Position declined from Sep. 2023 (€6.09 Mil) to Mar. 2024 (€1.39 Mil) but then increased from Mar. 2024 (€1.39 Mil) to Sep. 2024 (€2.18 Mil).

Oxford BioDynamics's annual Ending Cash Position increased from Sep. 2022 (€1.11 Mil) to Sep. 2023 (€6.09 Mil) but then declined from Sep. 2023 (€6.09 Mil) to Sep. 2024 (€2.18 Mil).

Oxford BioDynamics Ending Cash Position Historical Data

The historical data trend for Oxford BioDynamics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Ending Cash Position Chart

Oxford BioDynamics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Ending Cash Position

Get a 7-Day Free Trial

6.73

2.54

1.11

6.09

2.18

Oxford BioDynamics Semi-Annual Data
	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															1.11	1.36	6.09	1.39	2.18

Oxford BioDynamics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Oxford BioDynamics's Ending Cash Position for the fiscal year that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.257	+	-4.08
	=	2.18

Oxford BioDynamics's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.413	+	0.764
	=	2.18

Oxford BioDynamics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (STU:LMQ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

OXBOF:USA OBD:UK LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines